
Avantor Inc. (AVTR) Stock Forecast & Price Target
Avantor Inc. (AVTR) Analyst Ratings
Bulls say
Avantor is a global company that provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Despite facing headwinds from discrete customer comps and tariffs, the company's Laboratory Solutions and Bioscience Production segments showed strong order growth and a 1.1x book-to-bill ratio in Q2. While Avantor is undergoing a management transition and facing trade war risks and fierce competition, its solid market share in end markets with long-term growth potential along with potential improvements in operational execution and end market conditions make it a promising stock in the life sciences tools market.
Bears say
Avantor is one of the leading providers of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Despite the recent acquisition of VWR and its focus on consumables, Avantor's organic growth has been lackluster and forecasted to remain below competitors. While the company has implemented a sustainable strategy and has shown some improvement in its operations, it faces strong competition and the risk of continued share loss. Furthermore, the company's reliance on the wet lab research market could be challenged by the increasing use of dry labs and AI technology.
This aggregate rating is based on analysts' research of Avantor Inc. and is not a guaranteed prediction by Public.com or investment advice.
Avantor Inc. (AVTR) Analyst Forecast & Price Prediction
Start investing in Avantor Inc. (AVTR)
Order type
Buy in
Order amount
Est. shares
0 shares